Filing Details
- Accession Number:
- 0001144204-14-075351
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-22 16:24:24
- Reporting Period:
- 2014-12-19
- Filing Date:
- 2014-12-22
- Accepted Time:
- 2014-12-22 16:24:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1077183 | Neogenomics Inc | NEO | Services-Testing Laboratories (8734) | 742897368 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1627350 | H. Robert Horel | 12701 Commonwealth Drive Suite 9 Fort Myers FL US 33913 | Vice President Andgm Pathlogic | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-12-19 | 4,107 | $1.47 | 4,107 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-12-19 | 4,000 | $0.62 | 8,107 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-12-19 | 500 | $1.47 | 8,607 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2014-12-19 | 23,782 | $1.45 | 32,389 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-12-19 | 32,389 | $4.21 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2014-12-19 | 4,107 | $1.47 | 0 | $1.47 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2014-12-19 | 4,000 | $0.62 | 0 | $0.62 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2014-12-19 | 500 | $1.47 | 0 | $1.47 |
| Common Stock | Stock Option (Right to Buy) | Acquisiton | 2014-02-19 | 23,782 | $1.45 | 0 | $1.45 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2006-12-26 | 2016-12-25 | No | 4 | X | Direct |
| 0 | 2009-12-31 | 2019-02-02 | No | 4 | X | Direct |
| 0 | 2007-02-13 | 2017-02-12 | No | 4 | X | Direct |
| 26,218 | 2012-05-20 | 2016-05-19 | No | 4 | X | Direct |
Reported Derivative Holdings
| Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | $1.69 | 2012-04-12 | 2017-04-12 | 0 | 25,000 | Direct |
| Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
|---|---|---|---|
| 2017-04-12 | 0 | 25,000 | Direct |
Footnotes
- On December 26, 2006 Mr. Horel was granted 30,000 stock options. There was immediate vesting of 4,000 shares and the remaining shares had a combination of time based and performance based vesting. There were 8,000 shares cancelled from this grant.
- On February 2, 2009 Mr. Horel was granted 6,000 stock options. These shares had performance based vesting and the first performance milestone was on December 31, 2009. There were 2,000 shares cancelled from this grant because of a missed performance milestone.
- On February 13, 2007 Mr. Horel was granted 500 stock options which had immediate vesting.
- On May 20, 2011 Mr. Horel was granted 50,000 stock options. These shares vest ratably over the first four anniversaries of the grant date.
- On April 12, 2012 Mr. Horel was granted 25,000 stock options. There was immediate vesting of 6,250 shares and then 6,250 shares will vest on each of the first three anniversaries of the grant date.
Billionaire Hedge Funds
